BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4064710)

  • 21. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of dobutamine in children with cardiovascular failure.
    Schranz D; Stopfkuchen H; Jüngst BK; Clemens R; Emmrich P
    Eur J Pediatr; 1982 Sep; 139(1):4-7. PubMed ID: 7173256
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of the clinical usefulness of dobutamine administered orally.
    Noda Y; Yazaki S; Suzuki H; Shibanoki S; Ishikawa K
    Anaesth Intensive Care; 1988 Aug; 16(3):302-9. PubMed ID: 3189740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dobutamine infusions in stable, critically ill children: pharmacokinetics and hemodynamic actions.
    Berg RA; Donnerstein RL; Padbury JF
    Crit Care Med; 1993 May; 21(5):678-86. PubMed ID: 8482088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiopulmonary effects of dobutamine and norepinephrine in isoflurane-anesthetized foals.
    Craig CA; Haskins SC; Hildebrand SV
    Vet Anaesth Analg; 2007 Nov; 34(6):377-87. PubMed ID: 17696976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic support of the myocardium following aortocoronary bypass surgery: a comparative study.
    Balderman SC; Aldridge J
    J Clin Pharmacol; 1986 Mar; 26(3):175-83. PubMed ID: 3082942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of dobutamine in children.
    Driscoll DJ; Gillette PC; Duff DF; Nihill MR; Gutgesell HP; Vargo TA; Mullins CE; McNamara DG
    Am J Cardiol; 1979 Mar; 43(3):581-5. PubMed ID: 420107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dopamine and dobutamine in patients requiring postoperative circulatory support.
    DiSesa VJ; Gold JP; Shemin RJ; Collins JJ; Cohn LH
    Clin Cardiol; 1986 Jun; 9(6):253-6. PubMed ID: 3522003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
    Richard C; Ricome JL; Rimailho A; Bottineau G; Auzepy P
    Circulation; 1983 Mar; 67(3):620-6. PubMed ID: 6821904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Mikulic E; Cohn JN; Franciosa JA
    Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
    Cunha-Goncalves D; Perez-de-Sa V; Larsson A; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of dobutamine in cardiology].
    Baudet M; Rigaud M; Bardet J; Bourdarias JP
    Ann Anesthesiol Fr; 1978; 19(10):863-8. PubMed ID: 35060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of dobutamine in patients following open heart surgery.
    Sakamoto T; Yamada T
    Circulation; 1977 Mar; 55(3):525-33. PubMed ID: 837487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock.
    Kumar A; Schupp E; Bunnell E; Ali A; Milcarek B; Parrillo JE
    Crit Care; 2008; 12(2):R35. PubMed ID: 18318900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiorespiratory responses to an i.v. infusion of dobutamine in the intact anaesthetized dog.
    Orchard CH; Chakrabarti MK; Sykes MK
    Br J Anaesth; 1982 Jun; 54(6):673-9. PubMed ID: 7082527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Delius W; Himmler C; Volger E; Davidson J
    Dtsch Med Wochenschr; 1978 Dec; 103(48):1915-21. PubMed ID: 710319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
    Keller N; Sykulski R; Larsen J
    Clin Physiol; 1991 May; 11(3):199-210. PubMed ID: 1832602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.